| 标题 |
 Safety and tolerability of switching to bictegravir/emtricitabine/tenofovir alafenamide versus continuing dolutegravir/lamivudine in people living with HIV with neuropsychiatric comorbidities: Week 24 and 48 results from the Management of INSTI-associated Neuropsychiatric Disorders (MIND) clinical trial |
| 网址 | |
| DOI | |
| 其它 |
期刊：Int J Antimicrob Agents 作者：Perez-Valero I, Corona Mata D, Crussells Canales MJ, Velasco Arribas M, Mican Rivera R, Ryan P, Navarrete-Lorite MN, Tiraboschi J, Barrado-Cuchillo J, Molero Bonilla M, Artigues Serra F, Mena de Cea A, de la Fuente Moral S, Perez Stachowski X, Garcia Fraile LJ, Diaz Almidon M, Gil P, Ferreira Tata C, Rivero Juarez A, Rivero A 出版日期：2026-04-27 |
| 求助人 | |
| 下载 | 求助已完成，仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
东方元语
Kao
cdercder
wwww
Nole
学术文献互助
颂歌998
zzhc
Criminology34
sourggg
arniu2008
aajhajkahna
张欢馨
xing_xing
zy
aaaa
昏睡的蟠桃
sagitar
OK
东风
皖公网安备34019202002308
